Ulys, Llc - Net Worth and Insider Trading
Ulys, Llc Net Worth
The estimated net worth of Ulys, Llc is at least $11 Million dollars as of 2024-11-13. Ulys, Llc is the 10% Owner of Lexicon Pharmaceuticals Inc and owns about 9,564,159 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $11 Million. Details can be seen in Ulys, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ulys, Llc has not made any transactions after 2009-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ulys, Llc
Ulys, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ulys, Llc owns 3 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) , Agenus Inc (AGEN) , and eHealth Inc (EHTH) .
Click here to see the complete history of Ulys, Llc’s form 4 insider trades.
Insider Ownership Summary of Ulys, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2022-08-01 | director & 10 percent owner |
| AGEN | Agenus Inc | 2008-05-10 | 10 percent owner |
| EHTH | eHealth Inc | 2006-10-12 | 10 percent owner |
Ulys, Llc Latest Holdings Summary
Ulys, Llc currently owns a total of 1 stock. Ulys, Llc owns 9,564,159 shares of Lexicon Pharmaceuticals Inc (LXRX) as of October 15, 2009, with a value of $11 Million.
Latest Holdings of Ulys, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2009-10-15 | 9,564,159 | 1.19 | 11,381,349 |
Holding Weightings of Ulys, Llc
Ulys, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Ulys, Llc has made a total of 0 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 2,207,876 shares on October 15, 2009, which cost Ulys, Llc around $23 Million.
Insider Trading History of Ulys, Llc
- 1
Ulys, Llc Trading Performance
GuruFocus tracks the stock performance after each of Ulys, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ulys, Llc is 25.74%. GuruFocus also compares Ulys, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ulys, Llc within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ulys, Llc's insider trading performs compared to the benchmark.
Performance of Ulys, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.89 | | | | | |
| Relative Return to S&P 500(%) | 0.5 | | | | | |
Ulys, Llc Ownership Network
Ownership Network List of Ulys, Llc
Ownership Network Relation of Ulys, Llc
Ulys, Llc Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
Ulys, Llc is the director & 10 percent owner of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, Ulys, Llc made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
Ulys, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Ulys, Llc. You might contact Ulys, Llc via mailing address: C/o The Invus Group, Llc, 750 Lexington Avenue, 30th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
